You searched for COVID-19 - Page 16 of 33

XIFIN Buys OmniSYS, Bridges Lab to Pharmacy

Clinical Laboratory Trends / By Robert Michel

CEO SUMMARY: XIFIN’s acquisition of pharmacy technology company OmniSYS is the latest evidence that retail pharmacies are preparing to become a new front door to healthcare for consumers. The deal allows XIFIN to bring clinical lab information about patients directly to pharmacists while also helping retail pharmacies with clinical service billing and reimbursement needs as …

XIFIN Buys OmniSYS, Bridges Lab to Pharmacy Read More »

To access this post, you must purchase The Dark Report.

Ortho Clinical Diagnostics to Be Acquired by Quidel

In Vitro Diagnostics / By Robert Michel

CEO SUMMARY: In an announcement released before the end of 2021, Quidel said it had signed an agreement to acquire Ortho Clinical Diagnostics (OCD) for $6 billion. Laboratories that are customers of either company should expect changes after the deal closes as Quidel moves to integrate OCD. One IVD expert says Quidel will become more …

Ortho Clinical Diagnostics to Be Acquired by Quidel Read More »

To access this post, you must purchase The Dark Report.

Rural Hospital Lab Hits Automation Home Run

Laboratory Automation / By Robert Michel

CEO SUMMARY: With the hospital adding specialist physicians and at the same time enjoying sustained growth in outreach test volume, the lab was hit with the dual need to expand the in-house test menu and reconfigure workflow to handle predictions of ongoing growth in outreach testing. Sarah Bush Lincoln Health System’s laboratory examined bottlenecks in …

Rural Hospital Lab Hits Automation Home Run Read More »

To access this post, you must purchase The Dark Report.

January 10, 2022 Intelligence: Late-Breaking Lab News

Late Breaking Lab News / By Robert Michel

Imagine a medical lab temporarily closing because of the demand for too many tests! That’s just what happened at one of Australia’s largest medical lab companies. Australian Clinical Labs had to temporarily discontinue offering COVID-19 testing because test volumes had gotten too large. Australian Clinical Labs operates dozens of drive-through and walk-in testing sites in …

January 10, 2022 Intelligence: Late-Breaking Lab News Read More »

To access this post, you must purchase The Dark Report.

2021’s Top 10 Lab Stories Highlight Important Trends

TDR Insider / By Robert Michel

This is an excerpt of a 3,075-word article in the December 20, 2021 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: Much like 2020, the pandemic dominated our new list of the top 10 lab stories for 2021. Beyond COVID-19 testing, the virus …

2021’s Top 10 Lab Stories Highlight Important Trends Read More »

To access this post, you must purchase The Dark Report.

Volume XXVIII, No. 17 – December 20, 2021

This issue includes the annual Top 10 Lab Stories of the year, this year ranging from COVID-19 to ransomware attacks on labs to the Theranos trial. These stories are useful to use in strategic planning by lab directors and pathologists. Also in this issue, there’s a reprieve on PAMA fee cuts as Congress postpones the 2021 cuts for a year.

Congress Votes: No PAMA Price Cuts for 2022

Commentary and Opinion by R. Lewis Dark / By R. Lewis Dark

IT’S WELCOME NEWS THAT CONGRESS VOTED EARLIER THIS MONTH to defer the PAMA price cuts to the Clinical Laboratory Fee Schedule (CLFS) that were scheduled to take place in 2022. This is a positive development for the finances of the nation’s clinical labs, particularly the smaller, independent labs that are often the only local labs …

Congress Votes: No PAMA Price Cuts for 2022 Read More »

To access this post, you must purchase The Dark Report.

2021’s Top 10 Lab Stories Confirm Important Trends

Clinical Laboratory Trends / By Robert Michel

CEO SUMMARY: Much like 2020, the pandemic dominated our new list of the top 10 lab industry stories for 2021. Beyond COVID-19 testing, the virus crept its way into long-term trends, such as pathology jobs and technology innovation. New ways of delivering healthcare will need responses by clinical laboratories, as will significant developments in the …

2021’s Top 10 Lab Stories Confirm Important Trends Read More »

To access this post, you must purchase The Dark Report.

IVD Companies Report Record Sales as 2021 Draws to Close

In Vitro Diagnostics / By Robert Michel

JUDGING BY THE THIRD QUARTER FINANCIAL PERFORMANCE of the major in vitro diagnostics (IVD) manufacturers, the demand for COVID-19 testing continues to generate a substantial stream of revenue. During their respective conference calls with investors and financial analysts, IVD company leaders associated revenue growth with increased sales of tests and supplies while noting the gradual …

IVD Companies Report Record Sales as 2021 Draws to Close Read More »

To access this post, you must purchase The Dark Report.

PAMA Test Price Cuts Deferred: It’s a ‘Huge Win’ for Labs

Laboratory Billing / By Robert Michel

TWO BIPARTISAN VOTES IN THE U.S. HOUSE OF REPRESENTATIVES AND SENATE will save clinical laboratories from another year of deep payment cuts imposed under the Protecting Access to Medicare Act of 2014 (PAMA). “This is a huge win for clinical labs,” said Erin Will Morton, Senior Vice President for Washington, D.C.-based CRD Associates. Morton represents …

PAMA Test Price Cuts Deferred: It’s a ‘Huge Win’ for Labs Read More »

To access this post, you must purchase The Dark Report.

Search Results for: COVID-19